Retinoic acid inhibits uterotrophic activity of bisphenol A in adult ovariectomized rats

Journal of Nutritional Science and Vitaminology

Volumn 53, Issue 5, 2007, Pages 432-436

  Koda, Tomoko ^a,b   Morita, Masatoshi ^b,c   Imai, Hideki ^a,b  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

^c EHIME UNIVERSITY   (Japan)

Author keywords

Bisphenol A; In vivo; Rat; Retinoic acid; Uterotrophic assay

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; BROXURIDINE; EPOXIDE; POLYCARBONATE; RETINOIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG INHIBITION; ESTROGEN ACTIVITY; FEMALE; HORMONE INHIBITION; NICK END LABELING; NONHUMAN; OVARIECTOMY; RAT; UTERUS WEIGHT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BROMODEOXYURIDINE; CELL PROLIFERATION; DIETARY SUPPLEMENTS; FEMALE; FREE RADICAL SCAVENGERS; IN SITU NICK-END LABELING; ORGAN SIZE; OVARIECTOMY; PHENOLS; RATS; RATS, SPRAGUE-DAWLEY; TRETINOIN; UTERUS;

MUS; RATTUS;

EID: 36348967697     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.53.432     Document Type: Article

References (30)

1. Staples CA, Dorn PB, Klecka GM, O'Block ST, Harris LR. 1998. A review of the environmental fate, effects, and exposures of bisphenol A. Chemosphere 36: 2149-2173.
2. Steinmetz R, Brown NG, Allen DL, Bigsby RM, Ben-Jonathan N. 1997. The environmental estrogen bisphenol A stimulates prolactin release in vitro and in vivo. Endocrinology 138: 1780-1786.
3. Krishnan AV, Stathis P, Permuth SF, Tokes L, Feldman D. 1993. Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 132: 2279-2286.
4. Brotons JA, Olea-Serrano MF, Villalobos M, Pedraza V, Olea N. 1995. Xenoestrogens released from lacquer coatings in food cans. Environ Health Perspect 103: 608-612.
5. Koda T, Umezu T, Kamata R, Morohoshi K, Ohta T, Morita M. 2005. Uterotrophic effects of benzophenone derivatives and a p-hydroxybenzoate used in ultraviolet screens. Environ Res 98: 40-45.
6. Koda T, Soya Y, Negishi H, Shiraishi F, Morita M. 2002. Improvement of a sensitive enzyme-linked immunosorbent assay for screening estrogen receptor binding activity. Environ Toxicol Chem 21: 2536-2541.
7. Gaido KW, Leonard LS, Lovell S, Gould JC, Babai D, Portier CJ, McDonnell DP. 1997. Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxicol Appl Pharmacol 143: 205-212.
8. Sporn MB, Roberts AB. 1983. Role of retinoids in differentiation and carcinogenesis. Cancer Res 43: 3034-3040.
9. Vermot J, Fraulob V, Dolle P, Niederreither K. 2000. Expression of enzymes synthesizing (aldehyde dehydrogenase 1 and retinaldehyde dehydrogenase 2) and metabolizing (Cyp26) retinoic acid in the mouse female reproductive system. Endocrinology 141: 3638-3645.
10. Zheng WL, Bucco RA, Sierra-Rievera E, Osteen KG, Melner MH, Ong DE. 1999. Synthesis of retinoic acid by rat ovarian cells that express cellular retinoic acid-binding protein-II. Biol Reprod 60: 110-114.
11. McCormick AM, Napoli JL. 1982. Identification of 5,6-epoxyretinoic acid as an endogenous retinol metabolite. J Biol Chem 257: 1730-1735.
12. Fontana JA, Miranda D, Mezu AB. 1990. Retinoic acid inhibition of human breast carcinoma proliferation is accompanied by inhibition of the synthesis of a Mr 39,000 protein. Cancer Res 50: 1977-1982.
13. Muller P, Kietz S, Gustafsson JA, Strom A. 2002. The anti-estrogenic effect of all-trans-retinoic acid on the breast cancer cell line MCF-7 is dependent on HES-1 expression. J Biol Chem 277: 28376-28379.
14. Boettger-Tong HL, Stancel GM. 1995. Retinoic acid inhibits estrogen-induced uterine stromal and myometrial cell proliferation. Endocrinology 136: 2975-2983.
15. Demirpence E, Balaguer P, Trousse F, Nicolas JC, Pons M, Gagne D. 1994. Antiestrogenic effects of all-trans-retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms. Cancer Res 54: 1458-1464.
16. Takeyoshi M, Yamasaki K, Sawaki M, Nakai M, Noda S, Takatsuki M. 2002. The efficacy of endocrine disruptor screening tests in detecting anti-estrogenic effects downstream of receptor-ligand interactions. Toxicol Lett 126: 91-98.
17. Aikawa H, Koyama S, Matsuda M, Nakahashi K, Akazome Y, Mori T. 2004. Relief effect of vitamin A on the decreased motility of sperm and the increased incidence of malformed sperm in mice exposed neonatally to bisphenol A. Cell Tissue Res 315: 119-124.
18. Kanno J, Onyon L, Haseman J, Fenner-Crisp P, Ashby J, Owens W. 2001. The OECD program to validate the rat uterotrophic bioassay to screen compounds for in vivo estrogenic responses: phase 1. Environ Health Perspect 109: 785-794.
19. Branham WS, Zehr DR, Sheehan DM. 1993. Differential sensitivity of rat uterine growth and epithelium hypertrophy to estrogens and antiestrogens. Proc Soc Exp Biol Med 203: 608-612.
20. Cooke PS, Buchanan DL, Young P, Setiawan T, Brody J, Korach KS, Taylor J, Lunbahn DB, Cunha GR. 1997. Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium. Proc Natl Acad Sci USA 94: 6535-6540.
21. Katsuda SI, Yoshida M, Watanabe T, Kuroda H, Ando-Lu J, Takahashi M, Hayashi H, Maekawa A. 1999. Estrogen receptor mRNA in uteri of normal estrous cycling and ovariectomized rats by in situ hybridization. Proc Soc Exp Biol Med 221: 207-214.
22. Cook JC, Kaplan M, Davis LG, O'Connor JC. 1997. Development of a Tier 1 screening battery for detecting endocrine-active compounds (EACs). Reg Toxicol Pharmacol 26: 60-68.
23. Hunter DS, Hodges LC, Vonier PM, Fuchs-Young R, Got3 tardis MM, Walker CL. 1999. Estrogen receptor activation via activation function 2 predicts agonism of xenoestrogens in normal and neoplastic cells of the uterine myometrium. Cancer Res 59: 3090-3099.
24. Yokoyama Y, Takahashi Y, Hashimoto M, Shinohara A, Lian Z, Tamaya T. 1998. Effects of sex steroids on silver stained proteins of nucleolar organizer regions (Ag-NOR) in the rabbit uterus. Biotech Histochem 73: 202-210.
25. Papaconstantinou AD, Umbreit TH, Fisher BR, Goering PL, Lappas NT, Brown KM. 2000. Bisphenol A-induced increases in uterine weight and alternations in uterine morphology in ovariectomized B6C3F1 mice: role of estrogen receptor. Toxicol Sci 56: 332-339.
26. Nephew KP, Long X, Osborne E, Burke KA, Ahluwalia A, Bigsby RM. 2000. Effect of estradiol on estrogen receptor expression in rat uterine cell types. Biol Reprod 62: 168-177.
27. Liu Y, Lee MO, Wang HG, Li Y, Hashimoto Y, Klaus M, Reed JC, Zhang X. 1996. Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol Cell Biol 16: 1138-1149.
28. Ohta Y, Ichimura K. 2000. Proliferation markers, proliferating cell nuclear antigen, Ki67, 5-bromo-2′-deoxyuridine, and cyclin D1 in mouse olfactory epithelium. Ann Otol Rhinol Laryngol 109: 1046-1048.
29. Diel P, Olff S, Schmidt S, Michna H. 2002. Effects of the environmental estrogens bisphenol A, o,p′-DDT, p-tert-octylphenol and coumestrol on apoptosis induction, cell proliferation and the expression of estrogen sensitive molecular parameters in the human breast cancer cell line MCF-7. J Steroid Biochem Mol Biol 80: 61-70.
30. Seidlova-Wuttke D, Jarry H, Wuttke W. 2004. Pure estrogenic effect of benzophenone-2 (BP2) but not of bisphenol A (BPA) and dibutylphtalate (DBP) in uterus, vagina and bone. Toxicology 205: 103-112.